Table 3.
Baseline demographic, clinical, and biochemical characteristics of the subjects in the control and plant stanol ester groups.
| Variable | Control group n = 45 |
Plant stanol ester group n = 43 |
|---|---|---|
| Sex, male (n, %) | 22 (48.9) | 16 (37.2) |
| Age (years) | 47.7 ± 11.6 | 47.4 ± 10.9 |
| Body weight (kg) | 61.1 ± 11.0 | 61.2 ± 10.5 |
| Height (cm) | 159.9 ± 8.1 | 158.5 ± 9.4 |
| BMI (kg/m2) | 23.8 ± 3.2 | 24.3 ± 2.8 |
| Abdominal circumference (cm) | 85.1 ± 8.6 | 86.0 ± 8.9 |
| Premenopausal of the women (n, %) | 14 (60.9) | 14 (51.9) |
| Smoking habits, smokers (n, %) | 5 (11.1) | 7 (16.3) |
| Systolic blood pressure (mmHg) | 110 (103–123) | 118 (110–120) |
| Diastolic blood pressure (mmHg) | 70 (68–80) | 70 (70–80) |
| Fasting blood glucose (mg/dL) | 94 (88–98) | 95 (91–99) |
Data are presented as mean ± SD or median (quartile 1–quartile 3). Differences between control and plant stanol ester groups were not statistically significant (independent samples t-test, chi-square test).